Pfizer running out of options for consumer business
April 4, 2018Research and Development, Sales and Marketing P&G, Pfizer, Procter & Gamble, biotech, drugs, pharma, pharmaceutical
A surprise new name was thrown into the ring to take on Pfizer’s healthcare unit but speculation suggests that valuation …
Ex-Kite execs form a CAR T rival
April 4, 2018Research and Development, Sales and Marketing Allogene, Pfizer, biotech, drugs, pharma, pharmaceutical
After working to bring through Kite Pharma from the pre-clinical development stage to its final $12 billion acquisition by Gilead, …
Patient experience: Living with ovarian cancer
April 3, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Ingrid Copperman, feature, ovarian cancer, patient experience, pharma
Ingrid Copperman recounts the many ways she has dealt with her diagnosis, as well as how the power of social …
One centre for cancer diagnoses trialled
April 3, 2018Manufacturing and Production, Medical Communications, Sales and Marketing NHS, biotech, drugs, pharma, pharmaceutical
NHS England is trialling centres that should be able to provide rapid answers as to whether a patient has cancer …
Alkermes sent reeling as FDA refuses review of depression treatment
April 3, 2018Manufacturing and Production, Research and Development, Sales and Marketing Alkermes, FDA, depression, major depressive disorder, pharma
Alkermes shares were knocked down to their lowest level since October 2016 after it was revealed that the FDA had …
Rumours Allergan is looking to offload $5bn women’s health unit
April 3, 2018Manufacturing and Production, Sales and Marketing Allergan, Restasis, biotech, drugs, pharma, pharmaceutical
According to a piece by Bloomberg, Allergan is looking at options to divest its women’s health unit in a move …
AZ’s MedImmune signs $200m immuno-oncology partnership with Compugen
April 3, 2018Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Cancer, MedImmune, compugen, immunotherapy, oncology, pharma
AstraZeneca’s biologic R&D unit MedImmune is set to enter a partnership with Israeli drug firm Compugen to develop bi-specific and …
Celgene’s COO heads to the exit
April 3, 2018Manufacturing and Production, Medical Communications, Sales and Marketing Celgene, Mark Alles, Scott Smith, biotech, drugs, pharma, pharmaceutical
Celgene has had a rough six months, its share price since the beginning of October has dropped from $146 to …
Top Ten most popular articles on Pharmafile.com this week
March 29, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ablynx, Cancer, GSK, Hemlibra, MSD, Roche, Sun Pharma, Takeda, brexit, pharma, tecentriq, top ten
As we approach the Easter weekend, we at Pharmafocus hope all of our readers have a great long weekend, if …
bluebird backs own CAR-T prospect, takes option to co-develop with Celgene
March 29, 2018Sales and Marketing Bluebird Bio, CAR T, CAR-T, Celgene, biotech, drugs, pharma, pharmaceutical
Biotech companies showing faith in their own prospect drug candidates is not an unusual occurrence, some do it to extremes. …
Teva spared payout to GSK over patent infringement dispute
March 29, 2018Sales and Marketing Coreg, GSK, GlaxoSmithKline, Teva, carvedilol, heart failure, pharma
Teva has been spared a sizeable payout to GlaxoSmithKline after a federal judge overturned a US jury verdict demanding that …
Fujifilm bolsters healthcare with two biotech buys for $800m
March 29, 2018Sales and Marketing Fujifilm, biotech, drugs, pharma, pharmaceutical
Fujifilm has made no secret of the fact it is looking to switch up part of its core business to …
Takeda moots Shire move but big questions remain
March 28, 2018Sales and Marketing Shire, Takeda, biotech, drugs, pharma, pharmaceutical
Takeda is considering making a bold move for Shire, after announcing, as per UK regulations, that it may make an …
InSight Innovations to buy CureTech in $550m deal
March 28, 2018Research and Development, Sales and Marketing Cancer, CureTech, Insight Innovations, Pfizer, Teva, brain cancer, brain tumour, immunotherapy, israel
Israeli drug firm CureTech is be sold for the third time in four years, this time to InSight Innovations in …
Five deaths linked to Roche’s haemophilia drug Hemlibra
March 28, 2018Research and Development Genentech, Hemlibra, Roche, haemophilia, pharma
Roche has been rocked by the revelation that there have been five patient deaths linked to the use of its …
Pfizer seeks tax breaks in return for planned $456m facility
March 28, 2018Manufacturing and Production, Research and Development Michigan, Pfizer, biotech, drugs, pharma, pharmaceutical, tax break
Pfizer has submitted proposals to officials in Portage, Michigan, for a major expansion of its manufacturing site in the city. …
May hints at providing long-term funding plan for NHS
March 28, 2018Medical Communications, Research and Development Conservatives, NHS, Theresa May, UK government, biotech, drugs, pharma, pharmaceutical
After the news broke earlier in the week of a group of nearly 100 MPs calling for a parliamentary commission …
Brexit Health Alliance: Brexit and the impact on patient access to medicines
March 28, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brexit Health Alliance, brexit, feature, market access, pharma
On behalf of the Brexit Health Alliance, Sarah Collen, Senior Policy Manager at NHS Confederation, details the potential negative fallout …
New organ discovery has implications for cancer treatment
March 27, 2018Research and Development biotech, drugs, pharma, pharmaceutical
The discovery of an entirely new organ, the 80th to be discovered in the human body, could have serious implications …
Abbvie pays out over $3m after its testosterone replacement drug leads to heart attack
March 27, 2018Manufacturing and Production, Sales and Marketing AbbVie, Endo, GSK, androgel, heart attack, pharma
Abbvie has been ordered to pay over $3 million in damages to a man who asserts that the uise of …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
